Soc. Generale Knock-Out SNW/ DE000SU0Y286 /
| 2024-05-06 9:27:43 AM | Chg.0.00 | Bid5:34:27 PM | Ask5:34:27 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 8.91EUR | 0.00% | 8.98 Bid Size: 2,000 |
9.01 Ask Size: 2,000 |
SANOFI SA INHABER ... | 180.8115 EUR | 2078-12-31 | Put |
GlobeNewswire
2:00 PM
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose ...
GlobeNewswire
2:00 PM
Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer
GlobeNewswire
05-02
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
04-25
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
GlobeNewswire
04-23
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
GlobeNewswire
04-17
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...
GlobeNewswire
04-10
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Upda...
GlobeNewswire
04-09
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targe...
GlobeNewswire
03-14
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Busi...
GlobeNewswire
03-14
SMDG Announces Appointment of Industry Leader Dr. Zsuzsanna Devecseri to the Board of Directors
GlobeNewswire
03-11
Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance ...
GlobeNewswire
03-05
Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...
GlobeNewswire
02-28
Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...
GlobeNewswire
02-27
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlig...
